Sale!

IHC ERPRHER2NEUKI67

Original price was: ₦ 240,000.Current price is: ₦ 180,000.

-25%

The IHC ERPRHER2NEUKI67 test is crucial for assessing breast cancer markers. It detects hormone receptors and HER2/neu status, aiding in personalized treatment decisions. Priced at 240000 NGN, it offers insights that are vital for effective cancer management.

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Nigeria No1 Genetic DNA Lab
  • Customer support Call 08077798758
Guaranteed Safe Checkout

IHC ERPRHER2NEUKI67 Test

Introduction

The IHC ERPRHER2NEUKI67 test is a significant diagnostic tool used in the evaluation of breast cancer. This test measures the presence of specific receptors in tumor tissue, which are critical for determining the most effective treatment options for patients. Understanding these markers allows healthcare providers to tailor therapies to individual needs, thereby improving patient outcomes.

What the Test Measures

This test assesses the expression of estrogen receptors (ER), progesterone receptors (PR), HER2/neu, and Ki67, a marker for cell proliferation. These components play a vital role in understanding the biology of breast cancer and guiding treatment decisions.

Who Should Consider This Test

Individuals diagnosed with breast cancer or those exhibiting symptoms such as breast lumps, changes in breast shape, or unusual discharge should consider this test. Additionally, patients with a family history of breast cancer or those at higher risk due to genetic factors may benefit from this analysis.

Benefits of Taking the Test

  • Identifies hormone receptor status, which is crucial for hormone therapy decisions.
  • Assesses HER2 status, informing the use of targeted therapies.
  • Provides Ki67 levels to evaluate tumor aggressiveness and prognosis.
  • Helps in personalizing treatment plans, improving effectiveness.

Understanding Your Results

Results from the IHC ERPRHER2NEUKI67 test will indicate the status of ER, PR, HER2, and Ki67. Generally, results are interpreted as follows:

  • Positive ER/PR indicates potential benefit from hormone therapy.
  • Positive HER2 suggests eligibility for targeted therapies.
  • High Ki67 levels may indicate a more aggressive tumor.

It is essential to discuss your results with your healthcare provider to understand their implications fully.

Test Name and Price

Price Type Price (NGN)
Discount Price 180000 NGN
Regular Price 240000 NGN

Book the Test

To book the IHC ERPRHER2NEUKI67 test, please contact us at +2348077798758 or visit our website. Ensure you have a Doctor’s prescription ready, as it is required for testing, except for those undergoing surgery, pregnancy, or planning to travel abroad.

With a turnaround time of 6 days, our lab is dedicated to providing accurate and timely results for your health needs.